Currently, there is only one U.S. government-approved treatment available for fatty liver disease, Rezdiffra (resmetirom), ...

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic dysfunction-associated steatohepatitis (MASH) ...

The decision came in response to a February lawsuit from a compounding industry group against the U.S. Food and Drug ...